Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: crospovidone; aspartame; colloidal anhydrous silica; mannitol; microcrystalline cellulose; magnesium stearate; calcium silicate; flavour - rizatriptan odt gh is indicated for the acute treatment of migraine attacks with or without aura.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: aspartame; crospovidone; calcium silicate; colloidal anhydrous silica; magnesium stearate; mannitol; microcrystalline cellulose; flavour - rizatriptan odt is indicated for the acute treatment of migraine attacks with or without aura.

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: crospovidone; aspartame; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; calcium silicate; mannitol; flavour - rizatriptan-au is indicated for the acute treatment of migraine attacks with or without aura.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - wafer - excipient ingredients: glycine; mannitol; gelatin; aspartame; flavour - rizatriptan wafers-10mg is indicated for the acute treatment of migraine attacks with or without aura.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: mannitol; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; crospovidone; aspartame; calcium silicate; flavour - rizatriptan odt gh is indicated for the acute treatment of migraine attacks with or without aura.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: acesulfame potassium; silicon dioxide; sodium stearylfumarate; crospovidone; ethylcellulose; hypromellose; mannitol; colloidal anhydrous silica; flavour - for acute treatment of migraine attacks with or without aura.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: aspartame; colloidal anhydrous silica; crospovidone; magnesium stearate; mannitol; microcrystalline cellulose; calcium silicate; flavour - rizalt is indicated for the acute treatment of migraine attacks with or without aura.

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: calcium silicate; magnesium stearate; aspartame; mannitol; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; flavour - rizatriptan-au is indicated for the acute treatment of migraine attacks with or without aura.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: aspartame; microcrystalline cellulose; colloidal anhydrous silica; crospovidone; magnesium stearate; mannitol; calcium silicate; flavour - rizatriptan-medis is indicated for the acute treatment of migraine attacks with or without aura.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: magnesium stearate; mannitol; calcium silicate; crospovidone; colloidal anhydrous silica; aspartame; microcrystalline cellulose; flavour - rizatriptan actavis is indicated for the acute treatment of migraine attacks with or without aura.